|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.36 SEK | +0.56% |
|
+8.76% | +10.09% |
Spago Nanomedical AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.731 million. Revenue was SEK 2.47 million.
Net loss was SEK 9.42 million. Basic loss per share from continuing operations was SEK 0.08.
| 1st Jan change | Capi. | |
|---|---|---|
| +10.09% | 7.38M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M |
SPAGO NANOMEDICAL AB 
